|
1
|
Hofbauer LC, Brueck CC, Singh SK and
Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone
Miner Res. 22:1317–1328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Das S and Crockett JC: Osteoporosis - a
current view of pharmacological prevention and treatment. Drug Des
Devel Ther. 7:435–448. 2013.PubMed/NCBI
|
|
3
|
Schousboe JT, Tanner SB and Leslie WD:
Definition of osteoporosis by bone density criteria in men: Effect
of using female instead of male young reference data depends on
skeletal site and densitometer manufacturer. J Clin Densitom.
17:301–306. 2014. View Article : Google Scholar
|
|
4
|
Rachner TD, Khosla S and Hofbauer LC:
Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Montagnani A, Gonnelli S, Alessandri M and
Nuti R: Osteoporosis and risk of fracture in patients with
diabetes: An update. Aging Clin Exp Res. 23:84–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lechleitner M, Pils K, Roller-Wirnsberger
R, Beubler E, Gasser R, Mrak P, Hoppichler F and Pietschmann P:
Diabetes and osteoporosis: Pathophysiological interactions and
clinical importance for geriatric patients. Z Gerontol Geriatr.
46:390–397. 2013.In German. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wongdee K and Charoenphandhu N:
Osteoporosis in diabetes mellitus: Possible cellular and molecular
mechanisms. World J Diabetes. 2:41–48. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Watanabe R and Okazaki R: Diabetes
mellitus and osteoporosis. Diabetes mellitus and bone and calcium
metabolism. Clin Calcium. 22:1307–1314. 2012.In Japanese.
PubMed/NCBI
|
|
9
|
Motyl KJ, McCauley LK and McCabe LR:
Amelioration of type I diabetes-induced osteoporosis by parathyroid
hormone is associated with improved osteoblast survival. J Cell
Physiol. 227:1326–1334. 2012. View Article : Google Scholar
|
|
10
|
Vlassara H and Uribarri J: Advanced
glycation end products (AGE) and diabetes: Cause, effect, or both?
Curr Diab Rep. 14:4532014. View Article : Google Scholar :
|
|
11
|
Yamagishi S: Role of advanced glycation
end products (AGEs) in osteoporosis in diabetes. Curr Drug Targets.
12:2096–2102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamaguchi M: Role of nutritional zinc in
the prevention of osteoporosis. Mol Cell Biochem. 338:241–254.
2010. View Article : Google Scholar
|
|
13
|
Zhang X, Zhao Y, Chu Q, Wang ZY, Li H and
Chi ZH: Zinc modulates high glucose-induced apoptosis by
suppressing oxidative stress in renal tubular epithelial cells.
Biol Trace Elem Res. 158:259–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ruz M, Carrasco F, Rojas P, Codoceo J,
Inostroza J, Basfi-fer K, Valencia A, Vásquez K, Galgani J, Pérez
A, et al: Zinc as a potential coadjuvant in therapy for type 2
diabetes. Food Nutr Bull. 34:215–221. 2013.PubMed/NCBI
|
|
15
|
Ha H and Lee HB: Reactive oxygen species
and matrix remodeling in diabetic kidney. J Am Soc Nephrol. 14(8
Suppl 3): S246–S249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan YX, Gong YW, Guo Y, Lv Q, Guo C,
Zhuang Y, Zhang Y, Li R and Zhang XZ: Mechanical strain regulates
osteoblast proliferation through integrin-mediated ERK activation.
PLoS One. 7:e357092012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bruinsma JJ, Jirakulaporn T, Muslin AJ and
Kornfeld K: Zinc ions and cation diffusion facilitator proteins
regulate Ras-mediated signaling. Dev Cell. 2:567–578. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park SJ, Kim SH, Choi HS, Rhee Y and Lim
SK: Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA
synthetase promotes survival of osteoblasts by regulating
anti-apoptotic PI3K/Akt signaling. Bone. 45:994–1003. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brzóska MM, Rogalska J, Galazyn-Sidorczuk
M, Jurczuk M, Roszczenko A, Kulikowska-Karpińska E and
Moniuszko-Jakoniuk J: Effect of zinc supplementation on bone
metabolism in male rats chronically exposed to cadmium. Toxicology.
237:89–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gurban CV and Mederle O: The OPG/RANKL
system and zinc ions are promoters of bone remodeling by osteoblast
proliferation in postmenopausal osteoporosis. Rom J Morphol
Embryol. 52(3 Suppl): 1113–1119. 2011.PubMed/NCBI
|
|
21
|
Fung EB, Kwiatkowski JL, Huang JN,
Gildengorin G, King JC and Vichinsky EP: Zinc supplementation
improves bone density in patients with thalassemia: A double-blind,
randomized, placebo-controlled trial. Am J Clin Nutr. 98:960–971.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kumar SD, Vijaya M, Samy RP, Dheen ST, Ren
M, Watt F, Kang YJ, Bay BH and Tay SS: Zinc supplementation
prevents cardiomyocyte apoptosis and congenital heart defects in
embryos of diabetic mice. Free Radic Biol Med. 53:1595–1606. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang D, Yang M, Guo B, Cao J, Yang L and
Guo X: Zinc upregulates the expression of osteoprotegerin in mouse
osteo-blasts MC3T3-E1 through PKC/MAPK pathways. Biol Trace Elem
Res. 146:340–348. 2012. View Article : Google Scholar
|
|
24
|
Niewoehner CB, Allen JI, Boosalis M,
Levine AS and Morley JE: Role of zinc supplementation in type II
diabetes mellitus. Am J Med. 81:63–68. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jayawardena R, Ranasinghe P, Galappatthy
P, Malkanthi R, Constantine G and Katulanda P: Effects of zinc
supplementation on diabetes mellitus: A systematic review and
meta-analysis. Diabetol Metab Syndr. 4:132012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhuang X, Pang X, Zhang W, Wu W, Zhao J,
Yang H and Qu W: Effects of zinc and manganese on advanced
glycation end products (AGEs) formation and AGEs-mediated
endothelial cell dysfunction. Life Sci. 90:131–139. 2012.
View Article : Google Scholar
|
|
27
|
Wijesekara N, Krishnamurthy M,
Bhattacharjee A, Suhail A, Sweeney G and Wheeler MB:
Adiponectin-induced ERK and Akt phosphorylation protects against
pancreatic beta cell apoptosis and increases insulin gene
expression and secretion. J Biol Chem. 285:33623–33631. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
García-Pérez AI, Galeano E, Nieto E, Estañ
MC and Sancho P: Dequalinium induces cytotoxicity in human leukemia
NB4 cells by downregulation of Raf/MEK/ERK and PI3K/Akt signaling
pathways and potentiation of specific inhibitors of these pathways.
Leuk Res. 38:795–803. 2014. View Article : Google Scholar : PubMed/NCBI
|
